Ciclesonide
Back to searchMolecule Structure
Scientific Name
Ciclesonide
Description of the Drug
Ciclesonide is a glucocorticoid used in the symptomatic relief of nasal symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01410
http://www.drugbank.ca/drugs/DB01410
Brand Name(s)
Alvesco, Alvesco 160, Alvesco 80, Omnaris, Zetonna
Company Owner(s)
Covis Pharma Gmbh
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Glucocorticoid receptor | SINGLE PROTEIN | AGONIST | CHEMBL2034 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3688 | |||
DrugBank | DB01410 | |||
PubChem: Thomson Pharma | 14910303 | 14763472 | ||
PubChem | 6918155 | |||
LINCS | LSM-45682 | |||
Nikkaji | J561.842H | |||
BindingDB | 50247997 | |||
EPA CompTox Dashboard | DTXSID9046659 | |||
DrugCentral | 633 | |||
ChemicalBook | CB3717420 | |||
Guide to Pharmacology | 7469 | |||
rxnorm | ALVESCO | ZETONNA | OMNARIS | CICLESONIDE |
PubChem: Drugs of the Future | 12014485 | |||
ChEBI | 31397 | |||
ZINC | ZINC000003915154 |